| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT06556550 | Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative… | Oligometastatic Disease | Recruiting |
| Phase 2 | |||
| NCT06856603 | OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10… | Metastatic Disease | Recruiting |
| NCT06984146 | Nivo40-AVD for Advanced Classic Hodgkin Lymphoma | Hodgkin Lymphoma, Adult | Recruiting |
| NCT07400094 | Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable… | Squamous Cell Carcinoma of Head and Neck | Not Yet Recruiting |
| NCT07421141 | De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer | Breast Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07710040 | Preoperative Proton Irradiation for High-grade Brain Gliomas. | High Grade Gliomas | Recruiting |
| NCT07584668 | Safety, Tolerability and Pharmacokinetics of EM-I-2024 | Assess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid Tumor | Active, Not Recruiting |